Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
92.69%
Operating Margin
45.61%
Net Margin
45.49%
Efficiency Metrics
Revenue per Expense Ratio
1.94
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
89.17%
Income Tax Rate
0.00%
EPS
2.1600000000
Balance Sheet Analysis
Current Ratio
18.20
Cash Ratio
0.43
Working Capital
$817.11M
Debt to Equity
1.01
Debt to Assets
48.05%
Equity Ratio
47.51%
Cash Flow Analysis
Operating Cash Flow Ratio
52.90%
Free Cash Flow Ratio
47.99%
CapEx to Revenue
4.91%
Dividends Paid
$94.76M
Stock Buybacks
$1.62M
Total Shareholder Returns
$96.38M
Cash Position Change
95.45%
Key Takeaways (2023 FY)
Increased dividend payments by 0.10%
Detailed Growth Metrics
Core Performance
Revenue
12.61%
Net Income
-10.29%
EPS
-13.25%
Operating Income
-9.21%
Operational Efficiency
R&D Expenses
-100.00%
SG&A Expenses
2.45%
Operating Cash Flow
-1.12%
Free Cash Flow
8.09%
Balance Sheet Health
Assets
12.02%
Debt
16.08%
Book Value per Share
4.16%
Inventory
-100.00%
Shareholder Returns
Dividends per Share
0.10%
Shares Outstanding
3.45%
Long Term Trends
3Y Revenue/Share
17.51%
5Y Revenue/Share
11.87%
3Y Dividend/Share
-0.34%
5Y Dividend/Share
0.30%